Hereditary angioedema remains the main indication, as stanozolol can raise C1 esterase inhibitor levels sufficiently to prevent swelling episodes. Yes; Winstrol was the trade name for pharmaceutical stanozolol tablets that left the U.S. market in 2010, so any current prescription is necessarily compounded. Because stanozolol is a schedule III
